As of 2026-04-02, the EV/EBITDA ratio of Insmed Inc (INSM) is -36.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INSM's latest enterprise value is 35,753.02 mil USD. INSM's TTM EBITDA according to its financial statements is -971.45 mil USD. Dividing these 2 quantities gives us the above INSM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.0x - 11.5x | 8.9x |
| Forward P/E multiples | 7.8x - 15.9x | 11.7x |
| Fair Price | (37.06) - (52.93) | (47.43) |
| Upside | -122.5% - -132.1% | -128.8% |
| Date | EV/EBITDA |
| 2026-03-30 | -34.33 |
| 2026-03-27 | -32.46 |
| 2026-03-26 | -32.97 |
| 2026-03-25 | -33.13 |
| 2026-03-24 | -31.10 |
| 2026-03-23 | -32.17 |
| 2026-03-20 | -30.40 |
| 2026-03-19 | -32.18 |
| 2026-03-18 | -31.89 |
| 2026-03-17 | -32.16 |
| 2026-03-16 | -32.31 |
| 2026-03-13 | -31.18 |
| 2026-03-12 | -31.18 |
| 2026-03-11 | -31.15 |
| 2026-03-10 | -32.14 |
| 2026-03-09 | -31.98 |
| 2026-03-06 | -31.32 |
| 2026-03-05 | -32.08 |
| 2026-03-04 | -33.48 |
| 2026-03-03 | -32.84 |
| 2026-03-02 | -32.69 |
| 2026-02-27 | -33.36 |
| 2026-02-26 | -33.51 |
| 2026-02-25 | -33.20 |
| 2026-02-24 | -35.42 |
| 2026-02-23 | -35.51 |
| 2026-02-20 | -36.81 |
| 2026-02-19 | -35.95 |
| 2026-02-18 | -33.75 |
| 2026-02-17 | -33.62 |
| 2026-02-13 | -33.23 |
| 2026-02-12 | -32.66 |
| 2026-02-11 | -33.16 |
| 2026-02-10 | -33.18 |
| 2026-02-09 | -33.40 |
| 2026-02-06 | -33.48 |
| 2026-02-05 | -33.73 |
| 2026-02-04 | -34.05 |
| 2026-02-03 | -35.10 |
| 2026-02-02 | -34.39 |
| 2026-01-30 | -35.03 |
| 2026-01-29 | -35.24 |
| 2026-01-28 | -34.81 |
| 2026-01-27 | -36.31 |
| 2026-01-26 | -35.66 |
| 2026-01-23 | -34.88 |
| 2026-01-22 | -35.81 |
| 2026-01-21 | -34.91 |
| 2026-01-20 | -36.50 |
| 2026-01-16 | -36.04 |